Technical Analysis for MYX - Mayne Pharma Group Ltd  

Grade Last Price % Change Price Change
A 7.240 0.28% 0.020
MYX closed up 0.28 percent on Thursday, March 28, 2024, on 69 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Gapped Up Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Crossed Above 20 DMA Bullish 0.28%
Bollinger Band Squeeze Range Contraction 0.28%
BB Squeeze + Upper Band Touch Range Contraction 0.28%
Above Upper BB Strength 0.28%
Upper Bollinger Band Touch Strength 0.28%

   Recent Intraday Alerts

Alert Time
Down 1% about 21 hours ago
Fell Below Upper Bollinger Band about 22 hours ago
Rose Above Previous Day's High about 23 hours ago
Up 1% about 23 hours ago
Upper Bollinger Band Resistance 1 day ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Mayne Pharma Group Ltd   Description

Mayne Pharma Group Limited is a specialty pharmaceutical company, which focuses on applying its drug delivery capability to commercialize branded and generic pharmaceuticals. The Company also provides contract development and manufacturing services. It operates in four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the United States. The SBD segment markets and distributes specialty branded pharmaceutical products in the United States. The MCS segment is engaged in the provision of contract analytical and pharmaceutical development services to third-party customers in the United States. The MPI segment is engaged in Australian manufacture and sale of branded and generic pharmaceutical product globally and provision of contract manufacturing services to third-party customers within Australia.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Health Manufacturing Pharmaceutical Pharmaceuticals Pharmaceutical Industry Pharmaceuticals Policy Pharmaceutical Products Pharmaceutical Industry In China Drug Delivery Science And Technology In The People's Republic Of China Contract Manufacturing Contract Manufacturing Services Contract Services Pharmaceutical Companies Generic Drug Generic Pharmaceutical Product Generic Pharmaceutical Products Manufacturing Services Pharmaceutical Development

Is MYX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.35
52 Week Low 2.75
Average Volume 213,746
200-Day Moving Average 4.855
50-Day Moving Average 6.061
20-Day Moving Average 6.965
10-Day Moving Average 6.965
Average True Range 0.258
RSI (14) 69.04
ADX 42.98
+DI 33.701
-DI 13.120
Chandelier Exit (Long, 3 ATRs) 6.576
Chandelier Exit (Short, 3 ATRs) 7.164
Upper Bollinger Bands 7.246
Lower Bollinger Band 6.684
Percent B (%b) 0.99
BandWidth 8.066
MACD Line 0.271
MACD Signal Line 0.297
MACD Histogram -0.0268
Fundamentals Value
Market Cap 12.16 Billion
Num Shares 1.68 Billion
EPS -0.19
Price-to-Earnings (P/E) Ratio -38.11
Price-to-Sales 1.19
Price-to-Book 0.57
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.570
Resistance 3 (R3) 7.560 7.440 7.515
Resistance 2 (R2) 7.440 7.356 7.445 7.497
Resistance 1 (R1) 7.340 7.304 7.280 7.350 7.478
Pivot Point 7.220 7.220 7.190 7.225 7.220
Support 1 (S1) 7.120 7.136 7.060 7.130 7.002
Support 2 (S2) 7.000 7.084 7.005 6.983
Support 3 (S3) 6.900 7.000 6.965
Support 4 (S4) 6.910